Georgina L. Hold

researcher

Georgina L. Hold is …
instance of (P31):
humanQ5

External links are
P8446Gateway to Research person ID80B69636-C363-46F9-95BD-7427F8023FA4
P496ORCID iD0000-0001-7573-3397
P1153Scopus author ID8511757900

P69educated atUniversity of GlasgowQ192775
University of SurreyQ546976
P108employerUniversity of New South WalesQ734764
University of Aberdeen Institute of Medical SciencesQ85985103
P734family nameHoldQ37551801
HoldQ37551801
HoldQ37551801
P735given nameGeorginaQ1586600
GeorginaQ1586600
P106occupationresearcherQ1650915
P21sex or genderfemaleQ6581072

Reverse relations

author (P50)
Q34071463A comprehensive evaluation of colonic mucosal isolates of Sutterella wadsworthensis from inflammatory bowel disease
Q53336365A functional polymorphism of toll-like receptor 4 gene increases risk of gastric carcinoma and its precursors.
Q52565454Adaptive response of neonatal sepsis-derived Group B Streptococcus to bilirubin.
Q30700359Anaerostipes caccae gen. nov., sp. nov., a new saccharolytic, acetate-utilising, butyrate-producing bacterium from human faeces.
Q55052181Assessment of microbial diversity in human colonic samples by 16S rDNA sequence analysis.
Q37184247CD14-159C/T and TLR9-1237T/C polymorphisms are not associated with gastric cancer risk in Caucasian populations
Q81230976COX-2 expression in sporadic colorectal adenomatous polyps is linked to adenoma characteristics
Q39162563Changing molecular epidemiology of rotavirus infection after introduction of monovalent rotavirus vaccination in Scotland.
Q64914632Comparative genomics and genome biology of Campylobacter showae.
Q55303124Comparative genomics of Campylobacter concisus: Analysis of clinical strains reveals genome diversity and pathogenic potential.
Q37801005Could Helicobacter organisms cause inflammatory bowel disease?
Q33954947Detection of Campylobacter concisus and other Campylobacter species in colonic biopsies from adults with ulcerative colitis
Q60046758Development of a DNA-Based Method Aimed at Identifying the Fish Species Present in Food Products
Q38823939Drug transporter gene expression in human colorectal tissue and cell lines: modulation with antiretrovirals for microbicide optimization.
Q57063257Efficacy of different faecal microbiota transplantation protocols for infection: A systematic review and meta-analysis
Q33839318Enterohepatic helicobacter in ulcerative colitis: potential pathogenic entities?
Q28548592Expression of Genes for Drug Transporters in the Human Female Genital Tract and Modulatory Effect of Antiretroviral Drugs
Q36959156Expression of neutrophil gelatinase-associated lipocalin in colorectal neoplastic progression: a marker of malignant potential?
Q37440439Extending colonic mucosal microbiome analysis-assessment of colonic lavage as a proxy for endoscopic colonic biopsies
Q57138840Faecal microbiota transplantation as a treatment for inflammatory bowel disease: a national survey of adult and paediatric gastroenterologists in the UK
Q35719588First-Pass Meconium Samples from Healthy Term Vaginally-Delivered Neonates: An Analysis of the Microbiota.
Q28296759Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment
Q35974155Gastrointestinal Microbiota and Colon Cancer
Q36284993Genetic variation in C20orf54, PLCE1 and MUC1 and the risk of upper gastrointestinal cancers in Caucasian populations
Q34543335Genetic variation in the prostate stem cell antigen gene and upper gastrointestinal cancer in white individuals
Q30759225Growth requirements and fermentation products of Fusobacterium prausnitzii, and a proposal to reclassify it as Faecalibacterium prausnitzii gen. nov., comb. nov.
Q91653035Gut microbial biofilm composition and organisation holds the key to CRC
Q35562401Gut microbiota. Microbiota organization--a key to understanding CRC development.
Q34255700IBD-what role do Proteobacteria play?
Q60046759Identification of Flatfish (Pleuronectiforme) Species Using DNA-Based Techniques
Q60046760Identification of Hake Species (MerlucciusGenus) Using Sequencing and PCR−RFLP Analysis of Mitochondrial DNA Control Region Sequences
Q42910227Increase in NF-kappaB binding affinity of the variant C allele of the toll-like receptor 9 -1237T/C polymorphism is associated with Helicobacter pylori-induced gastric disease
Q35686407Inflammation and Cancer II. Role of chronic inflammation and cytokine gene polymorphisms in the pathogenesis of gastrointestinal malignancy.
Q37885755Innate immune sensors and gastrointestinal bacterial infections
Q83345848Isolation, growth on prebiotics and probiotic potential of novel bifidobacteria from pigs
Q34348466Lack of association between the rs2294008 polymorphism in the prostate stem cell antigen gene and colorectal neoplasia: a case-control and immunohistochemical study.
Q99550744Microbiome Understanding in Maternity Study (MUMS), an Australian prospective longitudinal cohort study of maternal and infant microbiota: study protocol
Q54288748Microbiota of de-novo pediatric IBD: increased Faecalibacterium prausnitzii and reduced bacterial diversity in Crohn's but not in ulcerative colitis.
Q88198010Molecular Analysis of the Microbiome in Colorectal Cancer
Q35533970Mucosal microbiome in patients with recurrent aphthous stomatitis
Q47731422Multi-omics differentially classify disease state and treatment outcome in pediatric Crohn's disease.
Q90518863Novel Campylobacter concisus lipooligosaccharide is a determinant of inflammatory potential and virulence
Q35154979Oligonucleotide probes that detect quantitatively significant groups of butyrate-producing bacteria in human feces
Q57281728Oral iron exacerbates colitis and influences the intestinal microbiome
Q91378314Other Helicobacters and the gastric microbiome
Q34485643Possible association between a genetic polymorphism at 8q24 and risk of upper gastrointestinal cancer
Q46284784Review article: the gut microbiome in inflammatory bowel disease-avenues for microbial management.
Q37644559Role of host genetics in fibrosis.
Q34407175Role of the gut microbiota in inflammatory bowel disease pathogenesis: what have we learnt in the past 10 years?
Q80993614Role of the polymorphic IL-1B, IL-1RN and TNF-A genes in distal gastric cancer in Mexico
Q47902314Screening of colorectal cancer: present and future.
Q36053072Sporadic colorectal cancer--role of the commensal microbiota.
Q89707150Systematic review: gastric microbiota in health and disease
Q46247978Systematic review: ileoanal pouch microbiota in health and disease.
Q61096348The Effect of Vitamin D on Intestinal Inflammation and Faecal Microbiota in Patients with Ulcerative Colitis
Q34445270The TLR4 D299G and T399I SNPs are constitutively active to up-regulate expression of Trif-dependent genes
Q35529988The fungal microbiota of de-novo paediatric inflammatory bowel disease
Q26785649The gut microbiota and host health: a new clinical frontier
Q34437334The gut microbiota, bacterial metabolites and colorectal cancer
Q35206520The gut microbiota, dietary extremes and exercise.
Q64057245The gut virome: the 'missing link' between gut bacteria and host immunity?
Q35106510The impact of different DNA extraction kits and laboratories upon the assessment of human gut microbiota composition by 16S rRNA gene sequencing
Q47122592The influence of early research experience in medical school on the decision to intercalate and future career in clinical academia: a questionnaire study
Q34648376The microaerophilic microbiota of de-novo paediatric inflammatory bowel disease: the BISCUIT study
Q28217318The microbiology of butyrate formation in the human colon
Q37928114The other Helicobacters
Q37676002The role of infection in the aetiology of inflammatory bowel disease
Q40596923Transporters for Antiretroviral Drugs in Colorectal CD4+ T Cells and Circulating α4β7 Integrin CD4+ T Cells: Implications for HIV Microbicides.
Q36530028Two-stage genome-wide methylation profiling in childhood-onset Crohn's Disease implicates epigenetic alterations at the VMP1/MIR21 and HLA loci.
Q60046766Use of Restriction Fragment Length Polymorphism To Distinguish between Salmon Species
Q42134594Vacuolating cytotoxin and variants in Atg16L1 that disrupt autophagy promote Helicobacter pylori infection in humans.
Q92091601Volatile organic compounds emitted from faeces as a biomarker for colorectal cancer

Search more.